Retatrutide is a novel therapeutic/treatment/medicine agent under investigation for the management/treatment/control of type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists/glucagon-like https://bookmark-dofollow.com/story26511826/retautide-a-promising-new-glp-1-receptor-agonist